By Steve Elliott
South Carolina state Sen. Tom Davis (R-Beaufort), author of a bill which made it legal for parents to possess the marijuana derivative cannabidiol (CBD) oil to control their children's seizures, plans to introduce another bill on January 13, the first day of the upcoming legislative session, to allow low-THC marijuana to be grown in the state. But state law enforcement has already expressed opposition to the plan.
Davis said he first heard about CBD oil from a constituent whose granddaughter in Charleston was having 80 to 90 seizures an hour, reports Steve Jones at The State. Within two weeks of his constituent's granddaughter getting CBD oil, Davis said, the seizures were reduced by 80 percent.
After researching, Sen. Davis learned that CBD oil had helped people in other states, so he introduced a bill which passed and was signed into law by Gov. Nikki Haley last summer. The new law made legal the possession of CBD oil to treat children with uncontrollable epileptic seizures, as long as it was authorized by a physician.
The bill limits the amount of tetrahydrocannabinol (THC) that can be in the oil (THC is the main psychoactive ingredient in marijuana). It is limited by the bill to just 0.09 percent, far below what is needed to produce a high.
By Steve Elliott
Electronic cigarettes containing extracts of marijuana -- but no psychoactive THC -- are about to hit the market in France any day now. The e-cigs contain cannabinoids, including cannabidiol (CBD), which give relaxing and pain-killing effects, according to the manufacturer.
Three young French entrepreneurs are launching the product, which launches before the end of December, and they claim it will be entirely legal, reports The Local.
"KanaVape brings you many of the benefits of cannabinoids without the psychotic effect of THC," claims the website of the product, due to go on sale this month in France.
"Vape pens" which allow consumers to inhale cannabis or tobacco vapor are increasingly popular in the United States. But they've been rare in Europe until now.
"By using only hemp with 5 percent CBD (Cannabidiol) and no THC, KanaVape provides you with a unique cannabinoids excperience," the company claims. "Cannabidiol is a non-psychotic cannabinoid, it will not make you 'high' but will help you relax." (Note the not-very-subtle substitution of the word "psychotic" for the proper term, "psychoactive," perhaps to demonize THC and make it seem more threatening -- a favorite, albeit quite deceptive, marketing strategy for "CBD-only" purveyors.)
CBD-rich hemp, which is grown legally to make products such as oil, rope, cloth, paper, and fuel, will be used to make the vapor mix.
By Steve Elliott
The federal Food and Drug Administration has given the University of Alabama at Birmingham the go-ahead to study the use of cannabidiol, a marijuana derivative, to treat seizures.
The university on Wednesday received FDA letters authorizing two studies, one for children and one for adults, according to UAB spokesman Bob Shepard, reports Kim Chandler at the Associated Press.
Parents of children with severe seizure disorders convinced the Alabama Legislature last year to pass a bill authorizing UAB's Department of Neurology to perform a study of cannabidiol (CBD), a nonpsychoactive component of marijuana.
Shepard said the FDA had requested some changes in the studies; those will go before a university review board next month, he said.
"It's hard to put in words the feelings you have as a dad with a daughter that could benefit from this," said Dustin Chandler. The legislation had become known as "Carly's Law" after Chandler's three-year-old daughter, who started having seizures at just eight weeks old.
Carly was eventually diagnosed with the rare genetic disorder CDKL5. Chandler, a police officer in Pelham, frequently appeared before the Legislature to advocate for the bill.
By Steve Elliott
A portable analyzer instrument called the Cannalyzer-420™ is now avaialble; the product is designed to measure marijuana potency including THC, CBD, and more, according to the makers, Seattle-based LightWave Science, Inc.
Infrared technology is used in the Cannalyzer, according to the company, similar to that used by the U.S. Department of Agriculture on farm products for more than a decade.
The patent-pending instrument allows more growers, extractors, and dispensaries to quickly determine the quality their cannabis using infrared technology with repeatable accuracy within 1 percent, according to LightWave Science, Inc.
The idea is to save lots of time by not having to continuously send cannabis samples to expensive testing laboratories. "Use it when purchasing trim for your extracts or new product opportunities arriving at your back door," the company advises.
The Cannalyzer-420 measures marijuana flowers and leaves for the percentage of THC, CBD, and moisture, using non-contact, non-destructive infrared technology, according to the company. The Cannalyzer is a "grind and measure" unit which works by grinding the product into a sample dish, then placing it onto the measurement area to see instant results displayed onscreen.
The small, lightweight case is 6"x11"x14", with internal battery for 8 hours of operation in the field, according to the company. No internet connection is required.
Options are available to additionally measure extracts such as oils and dabs, according to LightWave Science, Inc.
By Steve Elliott
BreedIT Corp., through its Israeli subsidiary, BreedIT Ltd., on Tuesday announced that its joint venture, KanaboSeed Ltd., has submitted applications for the registration of two new cannabis strains to the Israeli Ministry of Agriculture & Rural Development Plant Breeders' Rights Council.
The new varieties of marijuana are the first to be developed by the KanaboSeed organization since the venture was formed in August of this year. Characterized by phenotypic and genotypic traits, the strains were cultivated to achieve CBD-to-THC ratios identified by the company's Scientific Advisory Board as likely to be effective in the management of particular medical conditions.
"We formed KanaboSeed to leverage the horticultural expertise of Seach Ltd., a licensed Israeli medical cannabis grower, with the technical and research capabilities of BreedIT Ltd., as well as our iBreedIT software platform," said Dr. Oded Sagee, CEO of BreedIT Ltd. ":Working together we are able develop and evaluate new strains relatively quickly, thereby reducing the timeline from research to market.
"These two registration applications are just the first for what we anticipate will be a line of new potential cannabis varieties that KanaboSeed is developing to address specific medical uses," Dr. Sagee said. "We intend to capitalize on the commercialization of new varieties, as allowed by the laws and regulations, in Israel and other countries where regulation permits the use of medical cannabis."
UsCBDpur, an importer of CBD extracted from industrial hemp and containing no THC, on Tuesday announced that they are now offering 100 gram to 1 kilo lots.
UsCBDpur says its cannabidiol is non-synthetic and represents a breakthrough in the clean extraction of CBD from thousand year old cultivars of Asian hemp (old strains bred for high fiber with little regard for any THC content).
"UsCBDpur contains no heavy metals, no THC and no residual cannabinoids/terpenes," states a prepared releasea from the company. It is simply PURE CBD, consistently testing at 99%+ pure!"
The company has what it calls "an affordable 100g entry level" beginning at $12,000. This means they are charging a stiff $120 a gram even at that volume. Rick Simpson Oil (RSO) and Full Extract Cannabis Oil (FECO) often sell for $25 to $40 a gram in the medical marijuana community -- at the single-gram level -- for comparison purposes.
"We decided to provide affordable entry levels for smaller manufacturers and formulation or consultation companies," said company director David Mouser. "If you do the math, it's a 7:1 ratio in costs.
"Everyone will enjoy cutting their CBD oil costs," Mouser said. "And think of the possibilities of pure powder formulations! That's huge, plus it is 100 percent CLEAN."
Expanding from its home market in Los Angeles, Nestdrop, which calls itself "the country's first completely in-App, on-demand medical marijuana delivery service," is now available for San Francisco patients on Android smartphones and tablets.
Medical marijuana patients will be required to upload a photo of valid ID and either a doctor's recommendation or medical marijuana identification card to Nestdrop's securely encrypted vault to receive approval before ordering. Unlike other online medical marijuana delivery services, Nestdrop says it is the first to provide an entirely in-app marketplace experience and orders will be fulfilled within an hour or less.
Nestdrop's medical marijuana service is currently available on Android throughout San Francisco as well as parts of Oakland and San Jose. More cities in the Bay Area will be added regularly.
"Expanding into San Francisco marks a milestone for us as we continue our mission of providing a safe method for medical marijuana patients to get the medicine they need in a convenient, discrete fashion," said Nestdrop co-founder Michael Pycher. "We are also excited to be the first medical marijuana delivery service in two major markets, with more on the way."
Plans Expansion of Line Of Hemp CBD Oils to Compete with Leading Pharmaceutical Products
Florida-based nutraceuticals company Zappy, Inc. has agreed to acquire Browns Botanicals and plans to release proprietary hemp CBD formulations for potential aid in various ailments including anxiety, insomnia, fatigue, nausea, pain and other ailments.
The formulations were developed using Hemp CBD Oil derived from industrial hemp, which it says is legal in all 50 states and 40 countries. Browns Botanicals is a nutraceutical leader specializing in the highest purity legal Hemp CBD-rich botanical products.
"We are honored to have Browns Botanicals as the backbone of the hemp-derived cannabinoids and terpenes science that we are bringing to customers," said Mike "Zappy" Zapolin, CEO of Zappy Inc. "Browns is well known in the industry for having the very best CBD products, and testimonials from customers with various illnesses, including epilepsy and several different auto-immune issues, are incredible."
Browns Botanicals recently won the first ever "Best Non-Edible Medically Infused Product" at the 2014 Cannabis Cup with an Industrial Hemp-derived CBD oil product, beating out the competition with their CBDemu, which is being used by Olympic athletes and sports teams.
Pan's Ink and Michigan Hemp Company on Tuesday announced they have entered into a strategic supply agreement through which Pan's Ink will provide tailored, natural terpene mixtures in bulk to Michigan Hemp Company for use in MHC's hemp CBD products. Pan's Ink will distribute its terpene mixtures to MHC under the Pan's Ink brand, TerpAid™.
Terpenes are an essential part of hemp and cannabis medicine, just as are the cannabinoids, including cannabidiol (CBD). These aromatic compounds work in concert to promote healing and well being through the "entourage effect."
Pan's Ink is known in the legal cannabis, smoking accessories, and aromatherapy industries for its line of terpene customization products. These products are used by customers to target the effects of their legal cannabis or other herbal smoking products in order to provide consistent symptom relief.
Pan's Ink also supplies balanced terpene profiles in bulk form to manufacturers. "We are thrilled to be working with hemp pioneers Joe Brown and the Michigan Hemp Company in this new venture," said Jack Turner, CEO and Founder of Pan's Ink.
"Terpenes are an integral part of cannabis medicine, and our 100 percent natural terpenes are the best in the industry," Turner said. "Teaming up with Michigan Hemp Company will gain Pan's Ink a valuable new relationship and will allow Michigan Hemp Company to augment its already cutting-edge products."
Researchers announce that clinical trials involving anti-convulsive form of marijuana is showing "promise" in children
As promising results from clinical trials are announced in the use of medicinal cannabis (medical marijuana) to treat intractable epilepsy, those lawfully cultivating the plant in California are being raided by local law enforcement. Two gardens destroyed by police in the past two months in Mendocino County and Modesto contained a rare strain of medical marijuana rich in Cannabidiol (or CBD) used by children many of whom do not respond to other drug treatments.
On August 5, unidentified men in camouflage dropped from an unmarked helicopter onto the 120-acre property of Potter Valley resident and cancer survivor Susan Schindler, cutting down her lawfully cultivated medical marijuana plants. In addition to growing for herself, Schindler was cultivating rare strains of medical marijuana rich in CBD, a non-psychotropic constituent of the plant, which were being used orally by children with epilepsy.
Schindler was also cultivating plants rich in THCV, another active constituent (or cannabinoid) that was producing positive results for a patient with Parkinson's disease.
Pioneers in cultivating CBD (cannabidiol) genetics for over two years, Exhale Med Center, the #1 rated medical marijuana shop on Yelp, carries one of the rarest strains of CBD-rich cannabis found today, called “CBD Web.” This strain contains 16 percent CBD to 2 percent THC, a ratio high enough to comfort the parents of a sick child suffering from epilepsy, giving them the confidence that the child will not feel high while reaping the medicinal rewards.
CBD Web is a constant at Exhale Med Center, in addition to three variations of CBD-rich strain genetics, CBD edibles, tinctures, creams, Rick Simpson Oils, and many different forms of concentrates. With last year's release of Dr. Sanjay Gupta's CNN Special Weed, a demand has been created for highly concentrated CBD products that will help patients’ symptoms without giving them a psychoactive high.
Known as one of the elite shops in Los Angeles, Exhale Med Center is a Prop D compliant, “Pre-ICO,” medical marijuana pioneer, offering one of the best selections of strain variations in town, in every price range. From high-end indoor sativas and hybrids from the Bay Area and top shelf indicas from SoCal to the outdoor and green house varieties from Northern California’s ‘Emerald Triangle’, Exhale says its range of more than 50 strains offers a quality remedy for most ailments. This December will mark their first year anniversary in their new zone-compliant location at 980 North La Cienega Blvd, Suite 102, Los Angeles, CA 90069.
By Steve Elliott
South Carolina lawmakers earlier this year passed one of those "CBD only" bills that allow parents to possess cannabidiol oil, derived from the marijuana plant, for treatment of epileptic seizures. But CBD oil can't be legally made in South Carolina, and it's against federal law to transport it across state lines, so a new Medical Marijuana Study Committee is working out the details of how, exactly, to implement their new law.
That committee met for the first time on Wednesday at the South Carolina Statehouse in Columbia, reports Robert Kittle at WSPA.
CBD oil doesn't have the mind-altering effects of tetrahydrocannabinol (THC), the which gets users high. As written, South Carolina's CBD-only law is just for patients in a clinical trial to treat epilepsy, and it provides no way for them to legally obtain the oil.
Janel Ralph of Myrtle Beach, whose five-year-old daughter Harmony has lissencephaly, which causes seizures, wants the law expanded so that it's not just a clinical trial and not just for epilepsy. She said the law, as written, doesn't really help.
"You're saying you can get it," she said. "You're saying you can give it to your child, and yes we're going to let you do this. But then they're not giving you any way to actually get it legally."
By Steve Elliott
Oklahoma Governor Mary Fallin on Wednesday announced she wants to work with lawmakers in the next session of the Legislature to legalize cannabidiol oil (CBD) on a limited, medically supervised, trial-only basis.
CBD is a component of the marijuana plant; unlike THC (tetrahydrocannabinol), it does not produce a high. The compound has shown effectiveness in quelling seizures in toddlers with epilepsy and other conditions. The CBD oil isn't smoked; it is not considered a recreational drug.
"I do not support legalizing the recreational use of marijuana," Fallin said, reports Laura Noland at KFOR-TV. "Nor do I support a broadly defined 'medicinal' marijuana use that makes it easy for healthy adults and teenagers to find and buy drugs."
"I do support allowing potentially life-saving medicine to find its way to children in need," the Republican Governor said. "I am very interested in allowing limited, heavily supervised use of non-intoxicating CBD to be delivered on a trial basis to sick children in Oklahoma."
Rep. Jon Echols is preparing to lead a legislative study of allowing medical trials for CBD in treating children affected by severe seizures. Echols said he decided to take on the issue when his niece was told CBD may help with her medical condition.
The Herban Legends Collective scholarship fund announced on Monday that it has received a donation of CBD-rich tincture from LeBlanc CNE.
Located in White Center, Seattle, Washington, Herban Legends in a prepared statement said it has "a strong commitment to making medical marijuana available to as many patients as possible."
LeBlanc CNE is a grower and broker of medical cannabis with a firm belief that healthcare is a right, not a privilege. To that end, LeBlanc tithes itself and donates medical cannabis to Herban Legends.
LeBlanc's most recent donation was of a tincture, Batch #5, rich in cannabidiol (CBD), the non-psychoactive compound responsible for many of marijuana's healing effects.
CBD has been used with children suffering from seizures, PTSD, Crohn's disease, chronic pain, and a number of other conditions.
"LeBlanc is proud to support Herban Legend Collective's goal of bringing medical marijuana to an otherwise underserved neighborhood," said Jerry Whiting, founder of LeBlanc CNE. "How can anyone say ‘no' to alleviating the pain and suffering of others?"
According to Whiting, Batch #5 is an alcohol-based tincture made with cannabis strains like Harlequin and Cannatonic, as opposed to strains of marijuana high in THC favored by recreational users.
Batch #5 was made using 190-proof Everclear. LeBlanc CNE said its whole plant extraction method captured a wide range of cannabinoids and terpenes.
By Steve Elliott
Missouri Governor Jay Nixon on Monday signed legislation into law that allows the use of cannabidiol oil extracted from marijuana to treat epileptic seizures that can't be effectively treated by pharmaceuticals.
The legislation was sponsored by state Sen. Eric Schmitt (R-St. Louis County), whose 9-year-old son has epilepsy, reports the Associated Press.
Patients and parents who want to use CBD oil will be required to register with the Missouri Department of Health, and also have a neurologist verify that the patient's epilepsy hasn't responded to at least three other treatments. (Why on earth would they only use the most effective and least toxic option when all the others have been exhausted?)
When asked what all the Missouri families who had moved to Colorado for legal access to CBD oil should do, Gov. Nixon replied, "Move back to Missouri."
When pressed on the question of whether such families would be prosecuted, Gov. Nixon said, "It would be better to talk to the attorney general's office about that. All I know is the measure I signed today will help us move forward to make sure Missouri can provide these therapies to families in need."
The Truth About CBD